Clinical Validation of a CXCR4 Mutation Screening Assay for Waldenstrom Macroglobulinemia.

[1]  R. Advani,et al.  Clonal architecture of CXCR4 WHIM‐like mutations in Waldenström Macroglobulinaemia , 2016, British journal of haematology.

[2]  M. Piris,et al.  MYD88 (L265P) Somatic Mutation in Marginal Zone B-cell Lymphoma , 2015, The American journal of surgical pathology.

[3]  R. Advani,et al.  Ibrutinib in previously treated Waldenström's macroglobulinemia. , 2015, The New England journal of medicine.

[4]  S. Treon,et al.  CXCR4 WHIM‐like frameshift and nonsense mutations promote ibrutinib resistance but do not supplant MYD88L265P‐directed survival signalling in Waldenström macroglobulinaemia cells , 2015, British journal of haematology.

[5]  A. Roccaro,et al.  C1013G/CXCR4 acts as a driver mutation of tumor progression and modulator of drug resistance in lymphoplasmacytic lymphoma. , 2014, Blood.

[6]  S. Treon,et al.  Somatic mutations in MYD88 and CXCR4 are determinants of clinical presentation and overall survival in Waldenstrom macroglobulinemia. , 2014, Blood.

[7]  G. Lenz.  Waldenstrom macroglobulinemia: genetics dictates clinical course. , 2014, Blood.

[8]  S. Treon,et al.  The genomic landscape of Waldenstrom macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis. , 2014, Blood.

[9]  N. Lindeman,et al.  Detection of MYD88 L265P in peripheral blood of patients with Waldenström’s Macroglobulinemia and IgM monoclonal gammopathy of undetermined significance , 2014, Leukemia.

[10]  N. Gray,et al.  A mutation in MYD88 (L265P) supports the survival of lymphoplasmacytic cells by activation of Bruton tyrosine kinase in Waldenström macroglobulinemia. , 2013, Blood.

[11]  S. Treon.  XIII. Waldenström's macroglobulinaemia: an indolent B‐cell lymphoma with distinct molecular and clinical features , 2013, Hematological oncology.

[12]  N. Munshi,et al.  MYD88 L265P in Waldenström macroglobulinemia, immunoglobulin M monoclonal gammopathy, and other B-cell lymphoproliferative disorders using conventional and quantitative allele-specific polymerase chain reaction. , 2013, Blood.

[13]  N. Harris,et al.  MYD88 L265P somatic mutation in Waldenström's macroglobulinemia. , 2012, The New England journal of medicine.

[14]  L. Medeiros,et al.  Waldenström Macroglobulinemia: A Review of the Entity and Its Differential Diagnosis , 2012, Advances in anatomic pathology.

[15]  M. Dyer,et al.  Genetic variation in CXCR4 and risk of chronic lymphocytic leukemia. , 2009, Blood.

[16]  G. Diaz,et al.  WHIM syndrome: A defect in CXCR4 signaling , 2005, Current allergy and asthma reports.

[17]  R. Gorlin,et al.  Mutations in the chemokine receptor gene CXCR4 are associated with WHIM syndrome, a combined immunodeficiency disease , 2003, Nature Genetics.

[18]  M. Dimopoulos,et al.  Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia. , 2003, Seminars in oncology.

[19]  Masahiko Kuroda,et al.  Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development , 1998, Nature.